Dr. Peter J. Murphy, MD

Dr. Murphy practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Murphy's NPI, 1174574586, was assigned on May 12, 2006. Dr. Murphy graduated from University of Texas Medical School at Houston in 1988. Dr. Murphy holds Nebraska license 18772.

Dr. Murphy's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Murphy also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Murphy's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Murphy is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murphy practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Murphy's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Murphy is board certified in pulmonary disease by the American Board of Internal Medicine. Dr. Murphy is licensed in Nebraska.

CMS data shows 184 Medicare services from Dr. Murphy across 4 procedure codes in 2024, all of them office visits, for 172 Medicare patients. Medicare paid $12,820 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 172 Medicare patients who saw Dr. Murphy in 2024. The largest group is 65 to 74, with 72 patients. 73% of them have high blood pressure, and 70% have copd. 12% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murphy's median patient age at 70, with 66% women.

In 2024, Dr. Murphy wrote 780 Medicare Part D claims for 107 patients. 38% of them were for generic drugs. CMS names the drug for 657 of them, across 17 drugs with 11 or more claims each, at $318,399 in total drug cost. In 2023, CMS named 559 claims across 17 drugs.

Dr. Murphy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Murphy, published from 2012 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Cystic Fibrosis. Dr. Murphy has published most often in J Cyst Fibros. Dr. Murphy's most frequent co-authors are Sabin R. Bista, MD, Kartikeya Rajdev, MD and Marius C. Florescu, MD.

CMS Open Payments shows 38 general payments to Dr. Murphy from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Gilead Sciences, Inc. paid the most, $4,926.

Dr. Murphy graduated from University of Texas Medical School at Houston in 1988.